4J Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$360K Hold
1,377
– – 0.17% 81
2026
Q2
$347K Sell
1,377
-16
-1% -$3.44K 0.17% 76
2026
Q1
$303K Hold
1,393
– – 0.17% 81
2025
Q4
$318K Hold
1,393
– – 0.18% 73
2025
Q3
$323K Hold
1,393
– – 0.19% 69
2025
Q2
$259K Hold
1,393
– – 0.17% 82
2025
Q1
$292K Buy
1,393
+35
+3% +$6.8K 0.23% 69
2024
Q4
$241K Hold
1,358
– – 0.2% 75
2024
Q3
$268K Hold
1,358
– – 0.21% 75
2024
Q2
$233K Hold
1,358
– – 0.19% 79
2024
Q1
$247K Hold
1,358
– – 0.21% 80
2023
Q4
$210K Hold
1,358
– – 0.19% 83
2023
Q3
$202K Buy
+1,358
New +$199K 0.2% 84
2023
Q2
– Sell
-1,358
Closed -$216K – 87
2023
Q1
$216K Hold
1,358
– – 0.23% 73
2022
Q4
$219K Buy
+1,358
New +$208K 0.25% 71
2022
Q3
– Sell
-1,358
Closed -$208K – 70
2022
Q2
$208K Sell
1,358
-100
-7% -$15.3K 0.26% 62
2022
Q1
$236K Buy
+1,458
New +$212K 0.21% 65

Other funds holding ABBV

4J Wealth Management's ABBV Position: Q3 2026 in Review

4J Wealth Management held its AbbVie (ABBV) position steady in Q3 2026 at 1,377 shares worth $360K. The position accounts for 0.17% of the portfolio, ranked #81.

4J Wealth Management first reported a position in ABBV in Q1 2022 and has held it in 17 quarters since. 4,272 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • 4J Wealth Management held 1,377 shares of AbbVie worth $360K as of Q3 2026.
  • 4J Wealth Management left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.17% of 4J Wealth Management's portfolio in Q3 2026, its #81 holding.
  • 4J Wealth Management first reported a position in AbbVie in Q1 2022 and has held it in 17 quarters since.
  • 4,272 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on 4J Wealth Management's 13F filing for Q3 2026, filed 2 Nov 2026.